Team:Calgary/Project/Achievements
From 2010.igem.org
(Difference between revisions)
(13 intermediate revisions not shown) | |||
Line 91: | Line 91: | ||
<p> | <p> | ||
+ | |||
+ | <h2 style="color:#0066CC">Overview of things completed</h2> | ||
+ | |||
+ | |||
+ | <table> | ||
+ | <tr> | ||
+ | <td> | ||
+ | <img src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/19-1.png" border="0" alt="Photobucket"></img></td> | ||
+ | <td>malE, malE31, malEΔSS, ibpAB Fusion Promoter, cpxP Promoter</td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | |||
+ | |||
+ | <table> | ||
+ | <tr> | ||
+ | <td> | ||
+ | cpxR reporter, degP reporter, ibpAB reporter, malE generator, malE31 generator, pBad/araC reporters, malE31 generator with cpxR reporter circuit</td> | ||
+ | <td><img src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/20-1.png" border="0" alt="Photobucket"></img></td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | |||
+ | <table> | ||
+ | <tr> | ||
+ | <td> | ||
+ | <img src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/21-1-1.png" border="0" alt="Photobucket"></img> | ||
+ | <td>malE, malE31, ibpAB reporter, cpxR reporter, degP reporter</td> | ||
+ | </tr> | ||
+ | </table> | ||
<h2 style="color:#0066CC">Bronze Medal Requirements</h2> | <h2 style="color:#0066CC">Bronze Medal Requirements</h2> | ||
Line 115: | Line 143: | ||
<tr> | <tr> | ||
- | <td><img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /><br/> | + | <td><img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /><br/>Please see our <br/>Parts page <a href="https://2010.igem.org/Team:Calgary/Parts/Parts_Submitted"> here</a>.</td> |
<td>Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Parts</td> | <td>Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Parts</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td><img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /><br/> | + | <td><img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /><br/>Please see our <br/>Parts page <a href="https://2010.igem.org/Team:Calgary/Parts/Parts_Submitted"> here</a>.</td> |
<td>Submit DNA for at least one new BioBrick Part or Device to the Registry of Parts</td> | <td>Submit DNA for at least one new BioBrick Part or Device to the Registry of Parts</td> | ||
</tr> | </tr> | ||
Line 129: | Line 157: | ||
<table> | <table> | ||
<tr> | <tr> | ||
- | <td><img style="height: | + | <td><img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /> </td> |
<td><h3>Demonstrate that one of your parts works as expected</h3></td> | <td><h3>Demonstrate that one of your parts works as expected</h3></td> | ||
</tr> | </tr> | ||
Line 135: | Line 163: | ||
<ul> | <ul> | ||
- | <li> | + | <li>Using various methods of characterization, we confirmed that our CpxR reporter circuit was functional. In adition, our maltose binding protein (MalE) and mutant maltose binding protein (MalE31) were shown to be functional. Click <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization"> here</a> for more information.</li> |
- | + | ||
<table> | <table> | ||
<tr> | <tr> | ||
Line 144: | Line 171: | ||
</table> | </table> | ||
- | <li> | + | <li>The CpxR reporter, MalE31, and MalE were shown to be functional through characterization. Click <a href="https://2010.igem.org/Team:Calgary/Parts/Parts"> here</a> for more information.</li> |
- | + | ||
- | < | + | |
<h2 style="color:#0066CC">Gold Medal Requirements</h2> | <h2 style="color:#0066CC">Gold Medal Requirements</h2> | ||
Line 158: | Line 183: | ||
<ul> | <ul> | ||
- | <li> | + | <li>More characterization was given to the Registry of Standard Parts for the cpxR promoter as well as for the degP promoter. Details can be found on our characterization page <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization">here</a>. </li> |
- | < | + | |
</ul> | </ul> | ||
<table> | <table> | ||
<tr> | <tr> | ||
- | <td><img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /></td> | + | <td> <img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /></td> |
<td><h3>Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system </h3></td> | <td><h3>Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system </h3></td> | ||
</tr> | </tr> | ||
Line 170: | Line 194: | ||
<ul> | <ul> | ||
- | <li>We tested out a part for Lethbridge. We | + | <li>We tested out a part (nms6) for the University of Lethbridge. We assayed it for possible misfolding in the cytoplasm. Results can be found <a href="https://2010.igem.org/Team:Calgary/Parts/Characterization"> here</a>.</li> |
- | <li>We | + | <li> We attended an Alberta-wide conference where teams from the University of Calgary, the University of Lethbridge, and the University of Alberta did mock presentations, gave each other future directions, and gave possible troubleshooting methods.</li> |
- | <li> | + | <li>We filled out surveys for the University of Warsaw and the University of Edinburgh iGEM teams</li> |
+ | <table> | ||
+ | <tr> | ||
+ | <td> <img style="height:50px; width:50px;" src="http://i872.photobucket.com/albums/ab287/iGEMCalgary_2010/Checkmark.png" /></td> | ||
+ | <td><h3>Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation</h3></td> | ||
+ | </tr> | ||
+ | </table> | ||
- | <li> | + | <li>We chose to use current social media in the form of podcasts which covered different ethical issues pertaining to synthetic biology. These are posted <a href="https://2010.igem.org/Team:Calgary/Community/Podcasts">here</a>. In addition to this, an analysis of the social, ethical, and economical factors which our project dealt with was written and is posted <a href="https://2010.igem.org/Team:Calgary/Community/Ethics">here</a></li> |
</ul> | </ul> | ||
</p> | </p> | ||
+ | |||
+ | |||
</div> | </div> | ||
Latest revision as of 04:00, 28 October 2010
Achievements
Overview of things completed
malE, malE31, malEΔSS, ibpAB Fusion Promoter, cpxP Promoter |
cpxR reporter, degP reporter, ibpAB reporter, malE generator, malE31 generator, pBad/araC reporters, malE31 generator with cpxR reporter circuit |
malE, malE31, ibpAB reporter, cpxR reporter, degP reporter |
Bronze Medal Requirements
Register the team | |
Successfully complete and submit a project summary form | |
Create a Wiki which includes all the details of the project | |
Present a presentation and a poster at the iGEM Jamboree | |
Please see our Parts page here. |
Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Parts |
Please see our Parts page here. |
Submit DNA for at least one new BioBrick Part or Device to the Registry of Parts |
Silver Medal Requirements
Demonstrate that one of your parts works as expected |
- Using various methods of characterization, we confirmed that our CpxR reporter circuit was functional. In adition, our maltose binding protein (MalE) and mutant maltose binding protein (MalE31) were shown to be functional. Click here for more information.
- The CpxR reporter, MalE31, and MalE were shown to be functional through characterization. Click here for more information.
- More characterization was given to the Registry of Standard Parts for the cpxR promoter as well as for the degP promoter. Details can be found on our characterization page here.
- We tested out a part (nms6) for the University of Lethbridge. We assayed it for possible misfolding in the cytoplasm. Results can be found here.
- We attended an Alberta-wide conference where teams from the University of Calgary, the University of Lethbridge, and the University of Alberta did mock presentations, gave each other future directions, and gave possible troubleshooting methods.
- We filled out surveys for the University of Warsaw and the University of Edinburgh iGEM teams
- We chose to use current social media in the form of podcasts which covered different ethical issues pertaining to synthetic biology. These are posted here. In addition to this, an analysis of the social, ethical, and economical factors which our project dealt with was written and is posted here
Characterize the operation of at least one new BioBrick Part or Device and enter this information on the Parts or Device page via the Registry of Parts |
Gold Medal Requirements
Characterize or improve an existing BioBrick Part or Device and enter this information back on the Registry |
Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system |
Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation |